Clinical Trials Browser

Phase NA × Recruiting × regorafenib × Clear all

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

NCT06456515 2025-02-17

Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC

Phase NA Recruiting

30 enrolled

Gastrointestinal

Colorectal Neoplasms

Clinical Trials

REGOSTA

Regorafenib and Sintilimab in Combination with Electroacupuncture in MSS CRC